Construct and criterion validity of the euro Qol-5D in patients with systemic lupus erythematosus

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Wang, Su Li ^a   Wu, Bin ^a   Zhu, Li An ^b   Leng, Lin ^b   Bucala, Richard ^b   Lu, Liang Jing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONSTRUCT VALIDITY; CONTROLLED STUDY; CRITERION RELATED VALIDITY; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; DISCRIMINANT VALIDITY; DISEASE SEVERITY; EURO QUALITY OF LIFE 5D MEASUREMENT; FEMALE; HUMAN; INTERMETHOD COMPARISON; LUPUS QUALITY OF LIFE; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; QUALITY OF LIFE; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS DAMAGE INDEX; CHINA; CROSS-SECTIONAL STUDY; HEALTH SURVEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; QUALITY ADJUSTED LIFE YEAR; YOUNG ADULT;

ADULT; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PUBLIC HEALTH SURVEILLANCE; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; YOUNG ADULT;

EID: 84902511542     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098883     Document Type: Article

References (24)

1. Mok CC, Mak A, Chu WP, To CH, Wong SN (2005) Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore) 84: 218-224.
2. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, et al. (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82: 299-308.
3. Alarcon GS, McGwin G Jr, Uribe A, Friedman AW, Roseman JM, et al. (2004) Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum 51: 465-474.
4. Dua AB, Touma Z, Toloza S, Jolly M (2013) Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus. Curr Rheumatol Rep 15: 380.
5. Jolly M (2005) How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol 32: 1706-1708.
6. Grech P, Khamashta M (2013) Targeted therapies in systemic lupus erythematosus. Lupus 22: 978-986.
7. FDA approves Benlysta to treat lupus Series (2011) FDA approves Benlysta to treat lupus [cited 2011 December 3]; Available: http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm246489.htm.
8. Rudmik L, Drummond M (2013) Health economic evaluation: important principles and methodology. Laryngoscope 123: 1341-1347.
9. Kularatna S, Whitty JA, Johnson NW, Scuffham PA (2013) Health state valuation in low- and middle-income countries: a systematic review of the literature. Value Health 16: 1091-1099.
10. McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y, et al. (2007) Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum 57: 972-979.
11. Sullivan PW, Ghushchyan V (2006) Preference-Based EQ-5D index scores for chronic conditions in the United States. Med Decis Making 26: 410-420.
12. Group E (1990) EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16: 199-208.
13. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725.
14. Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29: 288-291.
15. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, et al. (1997) The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 40: 809-813.
16. Wang SL, Wu B, Leng L, Bucala R, Lu LJ (2013) Validity of LupusQoL-China for the assessment of health related quality of life in Chinese patients with systemic lupus erythematosus. PLoS One 8: e63795.
17. Aday LA, Cornelius LJ (1996) Designing and conducting health surveys. San Francisco, California: Jossey-Bass. 126 p.
18. Harrison MJ, Ahmad Y, Haque S, Dale N, Teh LS, et al. (2012) Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus. J Rheumatol 39: 735-742.
19. Jolly M, Pickard AS, Wilke C, Mikolaitis RA, Teh LS, et al. (2010) Lupus-specific health outcome measure for US patients: the LupusQoL-US version. Ann Rheum Dis 69: 29-33.
20. Veenhof C, Bijlsma JW, van den Ende CH, van Dijk GM, Pisters MF, et al. (2006) Psychometric evaluation of osteoarthritis questionnaires: a systematic review of the literature. Arthritis Rheum 55: 480-492.
21. McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4: 293-307.
22. Kuriya B, Gladman DD, Ibanez D, Urowitz MB (2008) Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum 59: 181-185.
23. Waldheim E, Elkan AC, Pettersson S, Vollenhoven R, Bergman S, et al. (2013) Health-related quality of life, fatigue and mood in patients with SLE and high levels of pain compared to controls and patients with low levels of pain. Lupus 22: 1118-1127.
24. Whitehurst DG, Bryan S, Lewis M (2011) Systematic review and empirical comparison of contemporaneous EQ-5D and SF-6D group mean scores. Med Decis Making 31: E34-44.